Boston Scientific Corporation has obtained CE Mark on the Vercise Neural Navigator 5 Software with STIMVIEW XT technology, which when used as part of the Vercise Genus Deep Brain Stimulation (DBS) Systems, can provide clinicians with simple and actionable data for efficient programming in the treatment of people living with Parkinson’s disease, essential tremor and dystonia says the company.

“We are now using image guided programming tools to optimally define the site of stimulation while we clinically assess the patient,” said Francesca Morgante, professor of Neurology and Eleonor Peel Chair for the study of Ageing at St. George’s University of London. ”This advancement in the technology has substantially cut down our programming time and allowed to improve the symptoms of our patients in a significant shorter time.”